Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated from Revision: v3.5.3 to Revision: v3.5.4, signaling a new software build. This is a routine maintenance update and does not modify the study details, eligibility criteria, or results content on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing Revision: v3.5.2, indicating a newer page/document revision rather than substantive study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange Detected- Site revision updated to v3.5.2 (previously v3.5.0).SummaryDifference0.0%

- Check58 days agoChange DetectedRevision note added: v3.5.0; removed revision note: v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded Revision: v3.4.2; removed the earlier notices for v3.4.1 and the government funding status message.SummaryDifference0.4%

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.